ML System has received the final report from a single-center clinical trial of the „Covid Detector” device in the scope of clinical usefulness, accuracy & specificity for non-invasive real-time, instant diagnostics of infections caused by SARS-CoV-2 virus. This concludes the research regarding the effectiveness of the device in relation to detection of the SARS-CoV-2 virus from exhaled air and swabs. The achieved results of accuracy (98,08%) and specificity (97,67%) significantly surpass the effectiveness of the tests with WHO recommendations and provide great possibilities for the application of the device in professional diagnostics.
The key advantage of Covid Detector is high effectiveness of the performed tests but also the results in real-time.
The device is currently undergoing the tests for effectiveness of detection of anti-bodies in blood samples. Simultaneously a research is led over the possibilities of the use of the device for professional medical diagnostics in detecting cancer cells and tuberculosis including detection of illness stages.
See other news